Reported 1 day ago
MEI Pharma, Inc. (NASDAQ: MEIP) has announced a significant step in its corporate strategy by securing a PIPE investment to sell 29,239,767 shares at $3.42 each, totaling around $100 million. This transaction positions MEI Pharma as the first and only publicly traded company to adopt Litecoin as a treasury reserve asset, enhancing its decentralized monetary asset capabilities alongside its pharmaceutical development initiatives.
Source: YAHOO